Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
Purpose Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has...
Saved in:
| Published in | Pharmacoepidemiology and Drug Safety Vol. 30; no. 2; pp. 237 - 247 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Chichester, UK
Wiley
01.02.2021
John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1053-8569 1099-1557 1099-1557 |
| DOI | 10.1002/pds.5150 |
Cover
| Summary: | Purpose
Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has not been thoroughly assessed in the United Kingdom Clinical Practice Research Datalink's (CPRD's) GOLD database. We explored the validity of algorithms to identify cardiovascular outcomes and risk factors and evaluated different outcome‐identification strategies using these algorithms for estimation of adjusted incidence rate ratios (IRRs).
Methods
First, we identified AMI, stroke, smoking, obesity, and menopausal status in a cohort treated for overactive bladder by applying computerized algorithms to primary care medical records (2004–2012). We validated these cardiovascular outcomes and risk factors with physician questionnaires (gold standard for this analysis). Second, we estimated IRRs for AMI and stroke using algorithm–identified and questionnaire–confirmed cases, comparing these with IRRs from cases identified through linkage with hospitalization/mortality data (best estimate).
Results
For AMI, the algorithm's positive predictive value (PPV) was >90%. Initial algorithms for stroke performed less well because of inclusion of codes for prevalent stroke; algorithm refinement increased PPV to 80% but decreased sensitivity by 20%. Algorithms for smoking and obesity were considered valid. IRRs based on questionnaire‐confirmed cases only were closer to IRRs estimated from hospitalization/mortality data than IRRs from algorithm‐identified cases.
Conclusions
AMI, stroke, smoking, obesity, and postmenopausal status can be accurately identified in CPRD. Physician questionnaire–validated AMI and stroke cases yield IRRs closest to the best estimate. |
|---|---|
| Bibliography: | Prior presentations Funding information Astellas Pharma Global Development, Inc. Part of this work was included in an oral presentation, “Validation of cardiovascular events and covariates in CPRD GOLD using questionnaires to general practitioners (GPs),” at the 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 2016, in Dublin, Ireland. Margulis A, Varas‐Lorenzo C, Bui C, McQuay L, Ziemiecki R, …, Arana A, et al. Validation of cardiovascular events and covariates in CPRD GOLD using questionnaires to general practitioners (GPs). Pharmacoepidemiol Drug Saf. 2016;25(S3):255‐256. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Funding information Astellas Pharma Global Development, Inc. |
| ISSN: | 1053-8569 1099-1557 1099-1557 |
| DOI: | 10.1002/pds.5150 |